@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C0012634 "disease"; ns1:C0030705 "patients"; ns1:C0206419 "coronavirus"; ns1:C0206750 "coronavirus"; ns1:C5401375 "coronavirus" . rdf:predicate ns2:TRIPLE_UID:falr4g99-TRIPLE-ABSTRACT-2 "see" . rdf:subject ns1:C0011777 "dexamethasone"; ns1:C0026565 "mortality"; ns1:C0026566 "mortality"; ns1:C0814225 "benefits" . rdfs:Triple-UID ns3:TRIPLE_UID:falr4g99-TRIPLE-ABSTRACT-2 "falr4g99-TRIPLE-ABSTRACT-2" . rdfs:sentence rdfs:label "OBJECTIVES The questions remained if mortality benefits with dexamethasone seen in patients with coronavirus disease 2019 (COVID)-19) also extend to other systemic corticosteroids such as methylprednisolone." . rdfs:triple rdfs:label "mortality benefits with dexamethasone seen in patients, with, coronavirus disease" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:47:05.979318"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "f2y3VgBOpWjGcdGApp3dzSXawcDkA93W5f43ExbFjPbF4kC1SXdoly0gXmL9ZOxr0VgnS48fkScfSFMmzKPHkwKyDvvFs/7vK8yVLVIsPepMctaD8xLanKaxoUuSA7pj4FBruSM5B3N4euHg6Cp9OMXBu3jL3tmLdEyrXfpvY14="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:47:05.979318"^^xsd:dateTime; prov:wasAttributedTo . }